News
BMRA
2.960
+0.34%
0.010
$1 Million Bet On Motorsport Games? Check Out These 4 Penny Stocks Insiders Are Buying
Benzinga · 3d ago
Eiger BioPharmaceuticals And 2 Other Penny Stocks Insiders Are Aggressively Buying
Benzinga · 01/26 14:18
BRIEF-Barnwell Industries Reaches Agreement With Its Largest Stockholders
Reuters · 01/23 11:04
Barnwell Industries, Inc. Reaches Cooperation And Support Agreement With Its Largest Stockholders
Benzinga · 01/23 11:03
Biomerica reports FQ2 results
Seeking Alpha · 01/16 06:30
Biomerica: H.Pylori Announcements Important To Keep An Eye On, Reaffirm Hold
Seekingalpha · 12/24/2022 14:00
BRIEF-Biomerica Inc Says On Dec 12, 2022, Steve Sloan Notified Co He Will Be Stepping Down From His Position As CFO
Reuters · 12/16/2022 22:05
Biomerica Receives Saudi, UAE Regulators' Approval for Colorectal Screening, Breast Cancer Tests
Biomerica Receives Saudi, UAE Regulators' Approval for Colorectal Screening, Breast Cancer Tests
MT Newswires · 12/08/2022 13:58
Biomerica Receives Kingdom Of Saudi Arabia Food And Drug Administration And Ministry Of Health Approval For Colorectal Screening And Breast Screening Tests In Saudi Arabia And UAE
Benzinga · 12/08/2022 13:20
Biomerica Receives KFDA and Ministry of Health Approval for Colorectal Screening and Breast Screening Tests in Saudi Arabia and UAE
Expands Commercialization Efforts in Areas with High Unmet NeedsIRVINE, Calif., Dec. 08, 2022 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) received clearance from the Kingdom of Saudi Arabia Food and Drug Administration (KFDA), and th...
GlobeNewswire · 12/08/2022 13:19
We Think Shareholders May Consider Being More Generous With Biomerica, Inc.'s (NASDAQ:BMRA) CEO Compensation Package
Shareholders will be pleased by the robust performance of Biomerica, Inc. ( NASDAQ:BMRA ) recently and this will be...
Simply Wall St. · 12/01/2022 10:12
Biomerica InFoods IBS Data Presented At 2022 American College Of Gastroenterology (ACG) Annual Scientific Meeting
Benzinga · 11/02/2022 12:21
Biomerica (BMRA) Stock Gets Boost From Walmart Sales Expansion
Investor Place · 10/14/2022 17:29
Walmart Expands Sales Of Biomerica's Aware Breast Self Exam To 2400 Stores
Benzinga · 10/14/2022 14:24
Avenue, IMARA lead healthcare gainers; Galecto, Travere among losers
Seekingalpha · 10/14/2022 14:00
Walmart To Expand Sales Of Biomerica's Aware Breast Self Exam; Product Will Now Be Available In Over 2400 Walmart Stores
Simple at-home device to increase sensitivity in breast self-exams   Early detection of breast cancer saves lives   About 80% of breast cancer is detected by women themselves who notice
Benzinga · 10/14/2022 13:19
Walmart to Expand Sales of Biomerica’s Aware® Breast Self Exam; Product will now be available in over 2400 Walmart stores
Simple at-home device to increase sensitivity in breast self-examsEarly detection of breast cancer saves livesAbout 80% of breast cancer is detected by women themselves who notice changes in their breast IRVINE, Calif., Oct. 14, 2022 (GLOBE NEWSWIRE) -- Bi...
GlobeNewswire · 10/14/2022 13:18
BRIEF-Biomerica Posts Qtrly Loss Of $0.16 Per Share
Reuters · 10/13/2022 21:11
Biomerica Q1 EPS $(0.16) Down From $(0.12) YoY, Sales $1.67M Up From $1.26M YoY
Biomerica (NASDAQ:BMRA) reported quarterly losses of $(0.16) per share. This is a 33.33 percent decrease over losses of $(0.12) per share from the same period last year. The company reported $1.67 million in sales this
Benzinga · 10/13/2022 20:52
Biomerica Reports 30% Surge in Net Sales in Fiscal Q1
Biomerica Reports 30% Surge in Net Sales in Fiscal Q1
MT Newswires · 10/13/2022 17:06
More
Webull provides a variety of real-time BMRA stock news. You can receive the latest news about Biomerica Inc through multiple platforms. This information may help you make smarter investment decisions.
About BMRA
Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products. The Company's products are used at the point-of-care in home and in physicians' offices and in hospital/clinical laboratories for detection and treatment of medical conditions and diseases. The Company also engages in the research, development, commercialization and in certain cases regulatory approval, of patented, diagnostic-guided therapy (DGT) products to treat gastrointestinal diseases, such as irritable bowel syndrome (IBS), and other inflammatory diseases. The Company’s diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances and other medical complications. The Company’s medical diagnostic products are sold primarily in two markets: clinical laboratories and point-of-care.